Adastra Holdings Ltd
OTC Pink - Current Information:XTXXFView on Canadian Exchange

  • LAST PRICE
    0.3000
  • TODAY'S CHANGE (%)
    0.2873 (2,262.2047%)
  • Bid / Lots
    0.0127/ 100
  • Ask / Lots
    0.9000/ 10
  • Open / Previous Close
    0.3000 / 0.0127
  • Day Range
    0.3000
    0.3000
  • 52 Week Range
    0.0127
    1.8500
  • Volume
    110

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Nov 6, 2024

      Show headlines and story abstract

    • 9:02AM ET on Wednesday Nov 06, 2024 by Dow Jones
      Companies Mentioned: XTRX

      Langley, British Columbia--(Newsfile Corp. - November 6, 2024) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2EP) ("Adastra" or the "Company"), a leading cannabis processor and producer of two top Canadian concentrates brands, with a focus on product innovation and commercialization for adult-use and medical markets, announces the entering into of a Share Purchase Agreement (the "Agreement"), between Adastra Labs Inc. (the "Vendor"), a wholly-owned subsidiary of the Company, and Majik Psilocybin Ventures Inc. (the "Purchaser"), effective November 5, 2024.

    • 9:01AM ET on Wednesday Nov 06, 2024 by Newsfile
      Companies Mentioned: XTXXF

      Langley, British Columbia--(Newsfile Corp. - November 6, 2024) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2EP) ("Adastra" or the "Company"), a leading cannabis processor and producer of two top Canadian concentrates brands, with a focus on product innovation and commercialization for adult-use and medical markets, announces the entering into of a Share Purchase Agreement (the "Agreement"), between Adastra Labs Inc. (the "Vendor"), a wholly-owned subsidiary of the Company, and Majik Psilocybin Ventures Inc. (the "Purchaser"), effective November 5, 2024.

Peers Headlines

No documents available